Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.568, 2008-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alteplase cost-effective option for acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. :
Access to resources
Recommend
Ezetimibe cost-effective option in statin intolerance
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 571, 2009-01 ,pp. :
Genetic screening for HCM a "highly cost-effective" option
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 602, 2010-01 ,pp. :
Eptifibatide cost-effective option for coronary interventions
Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. :
Sorafenib a cost-effective option in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 516, 2006-01 ,pp. :